You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

CURIUM Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CURIUM, and what generic and branded alternatives to CURIUM drugs are available?

CURIUM has nineteen approved drugs.

Summary for CURIUM

US Patents:	0
Tradenames:	16
Ingredients:	16
NDAs:	19

Drugs and US Patents for CURIUM

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Curium	PHOSPHOCOL P32	chromic phosphate p-32	INJECTABLE;INJECTION	017084-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Curium	SODIUM IODIDE I 131	sodium iodide i-131	SOLUTION;ORAL	016515-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Try a Trial				⤷ Try a Trial
Curium	ULTRA-TECHNEKOW FM	technetium tc-99m sodium pertechnetate generator	SOLUTION;INTRAVENOUS	017243-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Curium	SODIUM IODIDE I 131	sodium iodide i-131	CAPSULE;ORAL	016517-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Curium	SODIUM CHROMATE CR 51	sodium chromate cr-51	INJECTABLE;INJECTION	016708-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Curium	SODIUM IODIDE I 123	sodium iodide i-123	CAPSULE;ORAL	071909-001	Feb 28, 1989	AA	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Curium	THALLOUS CHLORIDE TL 201	thallous chloride tl-201	INJECTABLE;INJECTION	018150-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for CURIUM

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Curium	OCTREOSCAN	indium in-111 pentetreotide kit	INJECTABLE;INJECTION	020314-001	Jun 2, 1994	5,776,894	⤷ Try a Trial
Curium	OCTREOSCAN	indium in-111 pentetreotide kit	INJECTABLE;INJECTION	020314-001	Jun 2, 1994	6,123,916	⤷ Try a Trial
Curium	TECHNESCAN	technetium tc-99m oxidronate kit	INJECTABLE;INJECTION	018321-001	Approved Prior to Jan 1, 1982	4,432,963	⤷ Try a Trial
Curium	OCTREOSCAN	indium in-111 pentetreotide kit	INJECTABLE;INJECTION	020314-001	Jun 2, 1994	5,384,113	⤷ Try a Trial
Curium	TECHNESCAN	technetium tc-99m oxidronate kit	INJECTABLE;INJECTION	018321-001	Approved Prior to Jan 1, 1982	4,497,744	⤷ Try a Trial
Curium	TECHNESCAN MAG3	technetium tc-99m mertiatide kit	INJECTABLE;INJECTION	019882-001	Jun 15, 1990	5,573,748	⤷ Try a Trial
Curium	ULTRATAG	technetium tc-99m red blood cell kit	INJECTABLE;INJECTION	019981-001	Jun 10, 1991	4,755,375	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Curium

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.